SQI Diagnostics Inc., a life sciences company, develops and commercializes proprietary technologies and products for advanced multiplexing diagnostics in Canada. The company offers sqidworks diagnostic platform, a fully-automated microarray processing and analytical system; sqidlite benchtop diagnostic platform, a fully automated bench top microarray processing and analytical system; and sqid-X, a semi-automated bench-top platform. Its products are used in immunogenicity and bioanalysis, IVD and clinical, biomarkers, and assay development applications. SQI Diagnostics Inc. has a co-develop and licensing agreement with McMaster University Department of Engineering to develop chip technology for use in multi-array disease testing; and research and development agreements with University Health Network to create and license rapid multiplexed protein assays, as well as a point-of-care diagnostic device to enable transplant surgeons assess the suitability of lungs and other organs for transplantation. The company was founded in 1999 and is headquartered in Toronto, Canada.
Industry, Sector and Symbol
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+1-416-6749500
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$1.89 million
Profitability
Miscellaneous
Employees42
Next Earnings Date2/27/2020 (Estimated)
OptionableNot Optionable
SQI Diagnostics (CVE:SQD) Frequently Asked Questions
What is SQI Diagnostics' stock symbol?
SQI Diagnostics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SQD."
How were SQI Diagnostics' earnings last quarter?
SQI Diagnostics Inc. (CVE:SQD) posted its earnings results on Wednesday, December, 11th. The company reported ($0.01) EPS for the quarter. The business had revenue of $0.64 million for the quarter. View SQI Diagnostics' Earnings History.
When is SQI Diagnostics' next earnings date?
Has SQI Diagnostics been receiving favorable news coverage?
Press coverage about SQD stock has been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. SQI Diagnostics earned a daily sentiment score of 1.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for SQI Diagnostics.
Who are some of SQI Diagnostics' key competitors?
Some companies that are related to SQI Diagnostics include Lexagene (LXG), BARD1 Life Sciences (BD1), Oncimmune (ONC), Sernova (SVA), GeneNews (GEN), Imagion Biosys (IBX), LED Medical Diagnostics (LMD), Deepmatter Group (DMTR), Dorsavi (DVL), VentriPoint Diagnostics (VPT), Cambridge Cognition (COG), Smiles Inclusive (SIL), Lifespot Health (LSH), Genedrive (GDR) and Cryosite (CTE).
What other stocks do shareholders of SQI Diagnostics own?
Who are SQI Diagnostics' key executives?
SQI Diagnostics' management team includes the folowing people:
- Mr. Andrew Morris, CEO, Pres & Director (Age 53)
- Ms. Patricia Lie CPA, CA, VP of Fin. & Admin.
- Dr. Eric Brouwer, Chief Scientific Officer
- Dr. Peter Lea Ph.D., Founder (Age 74)
- Mr. Russell Peloquin, VP of Global Commercial Operations
How do I buy shares of SQI Diagnostics?
Shares of SQD and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is SQI Diagnostics' stock price today?
One share of SQD stock can currently be purchased for approximately C$0.08.
How big of a company is SQI Diagnostics?
What is SQI Diagnostics' official website?
How can I contact SQI Diagnostics?
SQI Diagnostics' mailing address is 36 Meteor Dr, ETOBICOKE, ON M9W 1A4, Canada. The company can be reached via phone at +1-416-6749500.
MarketBeat Community Rating for SQI Diagnostics (CVE SQD)
MarketBeat's community ratings are surveys of what our community members think about SQI Diagnostics and other stocks. Vote "Outperform" if you believe SQD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SQD will underperform the S&P 500 over the long term. You may vote once every thirty days.
